Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Irinotecan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04842526
What this trial is testing

Efficacy and Safety of Anlotinib, Irinotecan and Temozolomide in the Treatment of Refractory or Recurrent Neuroblastoma in Children: an Open, Single Arm, Single Center, Phase II Clinical Study

Who this might be right for
Refractory or Recurrent Neuroblastoma in Children
Tianjin Medical University Cancer Institute and Hospital 27
Testing effectiveness (Phase 2)Study completedNCT01220063
What this trial is testing

RSHF in Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Institut Cancerologie de l'Ouest 48
Testing effectiveness (Phase 2)UnknownNCT04569916
What this trial is testing

Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors

Who this might be right for
Solid Tumor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 30
Large-scale testing (Phase 3)Study completedNCT00112658
What this trial is testing

Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
UNICANCER 342
Early research (Phase 1)Study completedNCT00083148
What this trial is testing

Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer

Who this might be right for
Breast Cancer
Roswell Park Cancer Institute 12
Testing effectiveness (Phase 2)WithdrawnNCT00984438
What this trial is testing

Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
University of Cincinnati
Testing effectiveness (Phase 2)UnknownNCT01441349
What this trial is testing

Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
National Cancer Center, Korea 192
Testing effectiveness (Phase 2)Looking for participantsNCT06235216
What this trial is testing

Sacituzumab govitEcan in THYroid Cancers

Who this might be right for
Differentiated Thyroid CancerAnaplastic Thyroid Cancer
Grupo Espanol de Tumores Neuroendocrinos 42
Early research (Phase 1)Ended earlyNCT04239092
What this trial is testing

9-ING-41 in Pediatric Patients With Refractory Malignancies.

Who this might be right for
Refractory CancerRefractory NeoplasmCancer Pediatric+8 more
Actuate Therapeutics Inc. 40
Testing effectiveness (Phase 2)Study completedNCT00010036
What this trial is testing

Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
NYU Langone Health
Testing effectiveness (Phase 2)WithdrawnNCT01915472
What this trial is testing

A Phase II Study of IMMU 130 in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Gilead Sciences
Testing effectiveness (Phase 2)Ended earlyNCT00100828
What this trial is testing

Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 6
Early research (Phase 1)Study completedNCT00060567
What this trial is testing

Dose-Finding Study of E7070 in Combination With Irinotecan

Who this might be right for
Cancer
Eisai Inc. 88
Testing effectiveness (Phase 2)Ended earlyNCT03291899
What this trial is testing

Trial of Infusional FOLFIRINOX in First Line Treatment of Advanced Biliary Tract Cancers

Who this might be right for
Biliary Tract Cancer
King Faisal Specialist Hospital & Research Center 13
Testing effectiveness (Phase 2)Looking for participantsNCT05727163
What this trial is testing

FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients

Who this might be right for
Colorectal Cancer Metastatic
Sun Yat-sen University 194
Not applicableStudy completedNCT02256800
What this trial is testing

Escalated Dose of Irinotecan in mCRC

Who this might be right for
Metastatic Colorectal Cancer
Jaw-Yuan Wang, MD, PhD 213
Large-scale testing (Phase 3)Study completedNCT00005036
What this trial is testing

Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+13 more
National Cancer Institute (NCI) 560
Testing effectiveness (Phase 2)Active Not RecruitingNCT00248287
What this trial is testing

PhII ICb With/Without Erbitux in MBC Pts

Who this might be right for
Metastatic Breast Cancer
US Oncology Research 154
Not applicableLooking for participantsNCT07474103
What this trial is testing

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

Who this might be right for
Rectal Cancer, Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 49
Testing effectiveness (Phase 2)Study completedNCT00958386
What this trial is testing

Safety and Efficacy Study of Panitumumab+Irinotecan in Patients Wild-Type (WT) KRAS Metastatic Colorectal Cancer Refractory to Irinotecan Based Chemotherapy (SPECTRA)

Who this might be right for
Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 61
Next Page